Scientific Conference: CBD and Other Cannabinoids: Sex and Gender Differences in Use and Responses

Message from the Associate Commissioner

Dear Women’s Health Colleagues,

The FDA Office of Women’s Health is hosting a scientific conference to discuss potential sex (biological) and gender (psychosocial) differences in use and responses to cannabidiol (CBD) and other cannabinoids on November 19, 2020. We encourage you to attend this meeting which may be especially beneficial to researchers, public health practitioners, and consumers. 

Sincerely,

Kaveeta Vasisht, M.D., Pharm.D.

Associate Commissioner for Women's Health

Director, Office of Women's Health

Scientific Conference: CBD and Other Cannabinoids: Sex and Gender Differences in Use and Responses

This public meeting will provide further insight into the scientific evidence suggesting the presence or absence of sex and gender differences in use and responses to CBD and other cannabinoids. Conditions for which CBD is often marketed, such as chronic pain, anxiety, depression, and sleep disturbances, are more prevalent in women than men. Therefore, consideration of issues pertaining to the safety of CBD products may be particularly important to address in women. In addition, use of CBD and other cannabinoids during pregnancy is an important public health concern that will be highlighted at this meeting.

Register Today